Japan approves Medbed technology for mainstream media to block news
According to MedBedsTechnologyNew, Japan has become the first country in the world to officially approve the use of Medbed technology in public hospitals. The media completely blocked this news. July 17, 2026, Tokyo, Japan. Japan's Ministry of Health, Labour and Welfare has just issued Directive MHLW-2026-7714: ”Approving the clinical application of electromagnetic frequency regeneration equipment in national medical institutions”. This is neither a trial nor a study, but full approval.
Starting from September 1, 2026, 340 national hospitals across Japan will install electromagnetic frequency regeneration modules. Why did Japan take the lead in adopting this? Japan has the oldest population in the world. 29.1% of Japan's citizens are over 65 years old. Their healthcare system is collapsing under the weight of chronic disease management.
In 2024, Japan's healthcare spending reached $542 billion, 80% of which was used to treat diseases that could be eradicated with just one course of treatment using frequency technology. The Japanese government has calculated: the cost of lifelong cancer treatment for one patient: US$380,000; the cost of a single MedBed treatment: US$67 (electricity + maintenance: US$47); the cost savings per patient: US$379,953; and the annual cost savings nationwide: US$430 billion. Japan chose economic benefits over loyalty to pharmaceutical companies. They chose survival over inhibition.
Approved technology: Directive No. 2026-7714 of the Ministry of Health, Labour and Welfare of Japan explicitly authorizes three types of equipment
｜Type pulsed electromagnetic field regeneration chamber: 7.83-14.1Hz pulsed electromagnetic field for systemic treatment promotes cell regeneration. Approved indications: cancer, organ failure, autoimmune diseases.
Type II twisted-field DNA repair instrument: uses 528Hz scalar wave technology for targeted DNA repair. Approved indications: genetic diseases, reversal of aging, nerve damage.
Type II biophoton coherence restorer: uses full-spectrum light-frequency therapy to repair the immune system. Approved indications: rehabilitation after chronic infection X surgery, radiation damage.
These three types of equipment are “medical beds”. Japan has just granted them official medical classification numbers.
Pharmaceutical industry response:
Within three hours of the announcement: Pfizer Japan formally protested to the Ministry of Health, Labour and Welfare, Takeda Pharmaceutical's stock fell 11% on the Tokyo Stock Exchange, Astellas Pharma held an emergency board meeting, rumors circulated that the CEO would resign, and the Japan Pharmaceutical Industry Association called the move a “reckless endangerment of public health”. They actually called curing patients ”harming public health”. Their definition of “public health” is: making people sick forever and never able to pay.
Media Blockade: Just Google it now “approved by MedBed Japan” and you won't find anything. There is no CNN, no BBC, no Reuters, and no Associated Press. Nothing.
The fact that one of the Group of Seven (G7) members has just approved the most revolutionary medical technology in human history, while all Western media outlets have turned a blind eye, is not an oversight, but an organized suppression. In the United States alone, the pharmaceutical industry spends $6.58 billion annually on media advertising. This money was not only used to purchase advertising space, but also in Japanese, to seal the door.
What does this mean to you? Japan is a crack in the dam. Once a G7 member state approves a technology, other countries cannot continue to cover up the truth. The pressure will become unbearable. This science and technology has now been officially recognized by one of the world's most advanced healthcare systems.
